Report Overview

Middle East and Africa Radiotherapy Market – Industry Trends & Forecast Report, 2030

The Middle East and Africa Radiotherapy Market size by value was estimated at USD 138.19 million in 2023. During the forecast period between 2024 and 2030, the Middle East and Africa Radiotherapy Market size is projected to grow at a CAGR of 4.75% reaching a value of USD 265.02 million by 2030. Prominent drivers of the Middle East and Africa Radiotherapy Market include the rising incidence of cancer and the expanding utilization of radiotherapy equipment for cancer treatment. This trend is further fueled by a growing preference for non-surgical cancer treatment methods. For instance, data from the National Center for Biotechnology Information indicates that radiotherapy has the potential to enhance cure rates for 3.5 million cancer patients and provide palliative relief for an additional 3.5 million patients annually, amidst a backdrop of over 14 million new cancer cases each year. The increasing incidence of cancer worldwide, coupled with the diverse applications of radiotherapy, is expected to create favorable market opportunities.

Radiotherapy Market – Overview

Radiotherapy is primarily employed to manage tumor growth while minimizing damage to surrounding healthy tissue. It utilizes high-energy radiation, typically x-rays, to eradicate cancer cells and address tumors in various areas of the body, such as the prostate, breast, head & neck, and lungs. Recent advancements in radiotherapy have been notable, driven by enhancements in imaging technologies, robust computer systems, software, and delivery mechanisms, enabling more precise and effective treatment strategies.

Middle East and Africa Radiotherapy Market

Growth Drivers

Rising Prevalence of Cancer

The escalating incidence of cancer globally, particularly in developing regions like Africa, is driving demand for advanced radiotherapy solutions. With annual cancer diagnoses ranging from 3 to 7 million worldwide, and over 50% originating from developing countries, including those in Africa, the urgency to address this growing health concern is paramount. However, the availability of radiotherapy facilities in Africa remains insufficient, with only about 35% of countries possessing such infrastructure. This gap presents opportunities for market growth in the Middle East and Africa (MEA) region. Initiatives to bolster radiotherapy infrastructure, supported by organizations like the International Atomic Energy Agency (IAEA), are essential to meet the rising demand for cancer treatment.

Governments’ Supportive Initiatives

The Middle East and Africa Radiotherapy Market is gaining significant momentum due to the government initiatives. Notably, the WHO's strategic program launched in November 2020 aims at accelerating the eradication of cervical cancer through vaccination, screening, and treatment. In tandem, collaborations like that between the IAEA and WHO issued guidelines in March 2021 to enhance radiotherapy access, particularly in low and middle-income countries. These initiatives, emphasizing equipment selection, utilization, and quality maintenance, align with efforts to increase awareness and adoption of radiotherapy. In the context of the COVID-19 pandemic, African oncology communities have also developed guidelines to manage radiotherapy effectively amidst healthcare system challenges. Such governmental and organizational endeavors are pivotal in propelling the radiotherapy market forward, especially in emerging regions like the Middle East and Africa, with expected significant growth rates.

Challenges

High Cost of Equipment

The Middle East and Africa (MEA) Radiotherapy Market faces a significant hurdle in its growth trajectory due to the high cost of equipment. This financial barrier limits accessibility to advanced radiotherapy solutions for cancer treatment in the region. The expense of acquiring and maintaining radiotherapy equipment poses a challenge for healthcare facilities and governments, hindering their ability to invest in cutting-edge technologies. Consequently, many patients in the MEA region encounter barriers in accessing timely and effective cancer treatment, exacerbating the burden of the disease. Overcoming the challenge of equipment costs is essential to expanding access to radiotherapy and improving cancer care outcomes in the MEA region.

Impact of Geopolitical Tensions on Middle East and Africa Radiotherapy Market

Geopolitical tensions can significantly influence the Middle East and Africa Radiotherapy Market, creating uncertainties that impede market growth. These tensions can disrupt supply chains, hinder investment, and deter international collaborations essential for advancing radiotherapy technologies. Instability and conflict can also divert resources away from healthcare infrastructure development, including radiotherapy facilities. Additionally, geopolitical uncertainties may deter foreign investors and companies from entering the market, limiting access to innovative technologies and expertise. As a result, patients in regions affected by geopolitical tensions may face challenges in accessing timely and quality cancer treatment, exacerbating healthcare disparities and the burden of disease.

Middle East and Africa Radiotherapy Market

Segmental Coverage

Middle East and Africa Radiotherapy Market – By Type

By type, the Middle East and Africa Radiotherapy Market is divided into External-Beam Radiation Therapy, Internal Radiation Therapy, and Systematic Radiotherapy/Radiopharmaceuticals segments. The external-beam radiation therapy segment hods the highest share in the Middle East and Africa Radiotherapy Market by type. External-beam radiation therapy, which delivers high-energy radiation beams externally to target cancer cells, is widely utilized due to its effectiveness in treating various cancer types. Also, advancements in technology have enhanced the precision and efficacy of external-beam radiation therapy, making it a preferred choice among healthcare providers. Notably, the relative affordability and accessibility of external-beam radiation therapy equipment contribute to its prominence in the Middle East and Africa region.

Middle East and Africa Radiotherapy Market – By Product

Based on product, the Middle East and Africa Radiotherapy Market is divided into External-Beam Radiation Products, Internal Radiation Therapy Products, and Radiotherapy Software segments. The external-beam radiation products segment holds the highest share in the Middle East and Africa Radiotherapy Market by product. It is primarily driven by rising demand for devices like LINAC, proton therapy, cyberknife, and gamma knife. These are crucial for treating a spectrum of cancers including breast, lung, prostate, colorectal, lymphoma, liver, thyroid, brain, cervical, and spinal cancers, among others.

Middle East and Africa Radiotherapy Market – By Application

By application, the Middle East and Africa Radiotherapy Market is divided into Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, and Spine Cancer segments. The breast cancer segment holds the highest share in the Middle East and Africa Radiotherapy Market by application. Breast cancer represents a significant health challenge in the region, comprising 34% of new cancer cases and 22% of cancer-related deaths among women in 2020. With new breast cancer cases nearly doubling annually over the past two decades, there's a pressing need for enhanced patient care. The launch of the Policy Report "Improving Breast Cancer in the Middle East and Africa" underscores this urgency, offering insights into breast cancer care across nine MEA countries and aiming to facilitate policy decisions and the exchange of best practices in the region.

Middle East and Africa Radiotherapy Market – By End User

On the basis of end user, the Middle East and Africa Radiotherapy Market is divided into Hospitals, Radiation Therapy Centers, and Specialty Clinics segments. The hospitals segment holds the highest share in the Middle East and Africa Radiotherapy Market by end user. Hospitals serve as primary hubs for cancer treatment, equipped with radiotherapy facilities to cater to patient needs effectively. Given the rising prevalence of cancer in the region, hospitals play a crucial role in providing access to radiotherapy services. Additionally, hospitals often have specialized oncology departments staffed with trained professionals, ensuring comprehensive care for patients undergoing radiotherapy treatment. As a result, the hospitals segment holds the highest share, reflecting their central role in delivering radiotherapy services across the Middle East and Africa.

Middle East and Africa Radiotherapy Market – By Country

The in-depth research report on the Middle East and Africa Radiotherapy Market covers the market in the region’s major countries including Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, and Rest of MEA. South Africa holds the highest share in the Middle East and Africa Radiotherapy Market and is expected to maintain its dominance during the forecast period. It is primarily due to significant advancements in cancer treatment infrastructure. For instance, Groote Schuur Hospital's recent investment in state-of-the-art linear accelerator (LINAC) machines, each costing ZAR 47 million, underscores this commitment. These machines enable advanced radiotherapy techniques like volumetric modulated arc therapy and stereotactic body radiotherapy, enhancing treatment precision and patient outcomes. Also, the hospital's focus on comprehensive cancer care, including brachytherapy and orthovoltage treatments, further solidifies South Africa's position as a leader in radiotherapy advancements in the region.

Competitive Landscape

Major players operating in Middle East and Africa Radiotherapy Market include Elekta, Varian Medical Systems, VMCOGULF, Brainlab, GE Healthcare, Philips, Abbott Laboratories, Siemens, Sysmex Corporation, and Accuray. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

By Type

• External-Beam Radiation Therapy

• Internal Radiation Therapy

• Systematic Radiotherapy/Radiopharmaceuticals

By Product

• External-Beam Radiation Products

• Internal Radiation Therapy Products

• Radiotherapy Software

By Application

• Breast Cancer

• Lung Cancer

• Prostate Cancer

• Colorectal Cancer

• Lymphoma

• Liver Cancer

• Thyroid Cancer

• Brain Cancer

• Cervical Cancer

• Spine Cancer

By End User

• Hospitals

• Radiation Therapy Center

• Specialty Clinics

By Country

• Saudi Arabia

• UAE

• Qatar

• Kuwait

• South Africa

• Nigeria

• Algeria

• Rest of MEA

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3.  Middle East and Africa Radiotherapy Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
         1. Rising Prevalence of Cancer
         2. Government Initiatives
         3. Increasing Technological Advancements
      2. Restraints
         1. High Cost of Equipment
         2. Shortage of Skilled Professionals
         3. Limited Reimbursement
      3. Opportunities
         1. Telehealth and Remote Training
         2. Focus on Preventive Care
         3. Public-Private Partnerships
      4. Challenges
         1. Political and Economic Instability
         2. Fragmented Regulatory Landscape
   3. Technological Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. Middle East and Africa Radiotherapy Market: Marketing Strategies
5.  Middle East and Africa Radiotherapy Market Overview
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share and Forecast
      1. By Type
         1. External-Beam Radiation Therapy
         2. Internal Radiation Therapy
         3. Systematic Radiotherapy/Radiopharmaceuticals
         4. Others
      2. By Product
         1. External-Beam Radiation Products
         2. Internal Radiation Therapy Products
         3. Radiotherapy Software
         4. Others
      3. By Application
         1. Breast Cancer
         2. Lung Cancer
         3. Prostate Cancer
         4. Colorectal Cancer
         5. Lymphoma
         6. Liver Cancer
         7. Thyroid Cancer
         8. Brain Cancer
         9. Cervical Cancer
         10. Spine Cancer
         11. Others
      4. By End User
         1. Hospitals
         2. Radiation Therapy Center
         3. Specialty Clinics
         4. Others
      5. By Country
         1. Saudi Arabia
         2. UAE
         3. Qatar
         4. Kuwait
         5. South Africa
         6. Nigeria
         7. Algeria
         8. Rest of MEA
6. Saudi Arabia Radiotherapy Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Product
      3. By Application
      4. By End User
7. UAE Radiotherapy Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Product
      3. By Application
      4. By End User
8. Qatar Radiotherapy Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Product
      3. By Application
      4. By End User
9. Bahrain Radiotherapy Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Product
      3. By Application
      4. By End User
10. Kuwait Radiotherapy Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Type
       2. By Product
       3. By Application
       4. By End User
11. Oman Radiotherapy Market
    1. Market Size & Forecast, 2019–2030
    2. By Value (USD Million)
    3. Market Share & Forecast
    4. By Type
    5. By Product
    6. By Application
    7. By End User
12. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Middle East and Africa Radiotherapy Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
13. Impact of Escalating Geopolitical Tensions on Middle East and Africa Radiotherapy Market
14. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Elekta
    2. Varian Medical Systems
    3. VMCOGULF
    4. Brainlab
    5. GE Healthcare
    6. Philips
    7. Abbott Laboratories
    8. Siemens
    9. Sysmex Corporation
    10. Accuray
    11. Other Prominent Players
15. Key Strategic Recommendations
16. Research Methodology
    1.    Qualitative Research
       1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
       1.  Secondary Research
       2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Country
    5.    Assumptions & Limitations

* Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1       Middle East and Africa Radiotherapy Segmentation

Figure 2       Middle East and Africa Radiotherapy Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       Middle East and Africa Radiotherapy Market Size, By Value (USD Million), 2019–2030

Figure 5       Middle East and Africa Radiotherapy Market Share, By Type, By Value, 2019–2030

Figure 6       Middle East and Africa Radiotherapy Market Share, By Product, By Value, 2019–2030

Figure 7       Middle East and Africa Radiotherapy Market Share, By Application, By Value, 2019–2030

Figure 8       Middle East and Africa Radiotherapy Market Share, By End User, By Value, 2019–2030

Figure 9       Middle East and Africa Radiotherapy Market Share, By Country, By Value, 2019–2030

Figure 10     Saudi Arabia Radiotherapy Market Size, By Value (USD Million), 2019–2030

Figure 11     Saudi Arabia Radiotherapy Market Share, By Type, By Value, 2019–2030

Figure 12     Saudi Arabia Radiotherapy Market Share, By Product, By Value, 2019–2030

Figure 13     Saudi Arabia Radiotherapy Market Share, By Application, By Value, 2019–2030

Figure 14     Saudi Arabia Radiotherapy Market Share, By End User, By Value, 2019–2030

Figure 15     UAE Radiotherapy Market Size, By Value (USD Million), 2019–2030

Figure 16    

Figure 17     UAE Radiotherapy Market Share, By Product, By Value, 2019–2030

Figure 18     UAE Radiotherapy Market Share, By Application, By Value, 2019–2030

Figure 19     UAE Radiotherapy Market Share, By End User, By Value, 2019–2030

Figure 20     Qatar Radiotherapy Market Size, By Value (USD Million), 2019–2030

Figure 21     Qatar Radiotherapy Market Share, By Type, By Value, 2019–2030

Figure 22     Qatar Radiotherapy Market Share, By Product, By Value, 2019–2030

Figure 23     Qatar Radiotherapy Market Share, By Application, By Value, 2019–2030

Figure 24     Qatar Radiotherapy Market Share, By End User, By Value, 2019–2030

Figure 25     Bahrain Radiotherapy Market Size, By Value (USD Million), 2019–2030

Figure 26     Bahrain Radiotherapy Market Share, By Type, By Value, 2019–2030

Figure 27     Bahrain Radiotherapy Market Share, By Product, By Value, 2019–2030

Figure 28     Bahrain Radiotherapy Market Share, By Application, By Value, 2019–2030

Figure 29     Bahrain Radiotherapy Market Share, By End User, By Value, 2019–2030

Figure 30     Kuwait Radiotherapy Market Size, By Value (USD Million), 2019–2030

Figure 31     Kuwait Radiotherapy Market Share, By Type, By Value, 2019–2030

Figure 32     Kuwait Radiotherapy Market Share, By Product, By Value, 2019–2030

Figure 33     Kuwait Radiotherapy Market Share, By Application, By Value, 2019–2030

Figure 34     Kuwait Radiotherapy Market Share, By End User, By Value, 2019–2030

Figure 35     Oman Radiotherapy Market Size, By Value (USD Million), 2019–2030

Figure 36     Oman Radiotherapy Market Share, By Type, By Value, 2019–2030

Figure 37     Oman Radiotherapy Market Share, By Product, By Value, 2019–2030

Figure 38     Oman Radiotherapy Market Share, By Application, By Value, 2019–2030

Figure 39     Oman Radiotherapy Market Share, By End User, By Value, 2019–2030         

List of Tables

Table 1        Middle East and Africa Radiotherapy Market Size, By Value (USD Million), 2019–2030 

Table 2        Middle East and Africa Radiotherapy Market Size, By Type, By Value, 2019–2030         

Table 3        Middle East and Africa Radiotherapy Market Size, By Product, By Value, 2019–2030 

Table 4        Middle East and Africa Radiotherapy Market Size, By Application, By Value, 2019–2030 

Table 5        Middle East and Africa Radiotherapy Market Size, By End User, By Value, 2019–2030 

Table 6        Middle East and Africa Radiotherapy Market Size, By Country, By Value, 2019–2030 

Table 7        Saudi Arabia Radiotherapy Market Size, By Value (USD Million), 2019–2030

Table 8        Saudi Arabia Radiotherapy Market Size, By Type, By Value, 2019–2030

Table 9        Saudi Arabia Radiotherapy Market Size, By Product, By Value, 2019–2030    

Table 10      Saudi Arabia Radiotherapy Market Size, By Application, By Value, 2019–2030

Table 11      Saudi Arabia Radiotherapy Market Size, By End User, By Value, 2019–2030  

Table 12      UAE Radiotherapy Market Size, By Value (USD Million), 2019–2030              

Table 13      UAE Radiotherapy Market Size, By Type, By Value, 2019–2030           

Table 14      UAE Radiotherapy Market Size, By Product, By Value, 2019–2030                 

Table 15      UAE Radiotherapy Market Size, By Application, By Value, 2019–2030            

Table 16      UAE Radiotherapy Market Size, By End User, By Value, 2019–2030     

Table 17      Qatar Radiotherapy Market Size, By Value (USD Million), 2019–2030   

Table 18      Qatar Radiotherapy Market Size, By Type, By Value, 2019–2030

Table 19      Qatar Radiotherapy Market Size, By Product, By Value, 2019–2030     

Table 20      Qatar Radiotherapy Market Size, By Application, By Value, 2019–2030

Table 21      Qatar Radiotherapy Market Size, By End User, By Value, 2019–2030   

Table 22      Bahrain Radiotherapy Market Size, By Value (USD Million), 2019–2030

Table 23      Bahrain Radiotherapy Market Size, By Type, By Value, 2019–2030

Table 24      Bahrain Radiotherapy Market Size, By Product, By Value, 2019–2030           

Table 25      Bahrain Radiotherapy Market Size, By Application, By Value, 2019–2030       

Table 26      Bahrain Radiotherapy Market Size, By End User, By Value, 2019–2030         

Table 27      Kuwait Radiotherapy Market Size, By Value (USD Million), 2019–2030 

Table 28      Kuwait Radiotherapy Market Size, By Type, By Value, 2019–2030                 

Table 29      Kuwait Radiotherapy Market Size, By Product, By Value, 2019–2030   

Table 30      Kuwait Radiotherapy Market Size, By Application, By Value, 2019–2030                  

Table 31      Kuwait Radiotherapy Market Size, By End User, By Value, 2019–2030 

Table 32      Oman Radiotherapy Market Size, By Value (USD Million), 2019–2030  

Table 33      Oman Radiotherapy Market Size, By Type, By Value, 2019–2030

Table 34      Oman Radiotherapy Market Size, By Product, By Value, 2019–2030    

Table 35      Oman Radiotherapy Market Size, By Application, By Value, 2019–2030

Table 36      Oman Radiotherapy Market Size, By End User, By Value, 2019–2030  

Table 37      Elekta Company Overview

Table 38      Elekta Financial Overview

Table 39      Varian Medical Systems Company Overview

Table 40      Varian Medical Systems Financial Overview

Table 41      VMCOGULF Company Overview

Table 42      VMCOGULF Financial Overview

Table 43      Brainlab Company Overview

Table 44      Brainlab Financial Overview

Table 45      GE Healthcare Company Overview

Table 46      GE Healthcare Financial Overview

Table 47      Philips Company Overview

Table 48      Philips Financial Overview

Table 49      Abbott Laboratories Company Overview

Table 50      Abbott Laboratories Financial Overview

Table 51      Sysmex Corporation Company Overview

Table 52      Sysmex Corporation Financial Overview

Table 53      Siemens Company Overview

Table 54      Siemens Financial Overview

Table 53      Other Prominent Players Company Overview

Table 54      Other Prominent Players Financial Overview